JSF-58853-75869
2 vaccinations
1 coded response
24 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 741 / OK
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-09
Registered in v-safe
-
2021-04-09
Dose 1 — Pfizer-BioNTech
- 2021-04-09
-
2021-04-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-23
-
2021-04-30
Dose 2 — Pfizer-BioNTech
- 2021-04-30
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-05-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-07
- 2021-05-14
- 2021-05-28
- 2021-06-06
- 2021-06-11
- 2021-08-03
- 2021-11-03
-
2022-05-01
Survey response — 12 months, dose 2MedDRA: No adverse event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: naMedDRA releases: 2024-11 · check-in free text available
-
2022-05-01
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-05-02
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 11 — 12 months, dose 2
Symptoms: na
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release